Biotech

All Articles

Pfizer takes $230M attacked after axing neglected DMD genetics therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene treatment failure has actually gone a $230 ...

AC Immune observes 'landmark' potential in Alzheimer's drug data

.After greater than twenty years of deal with neurodegenerative health conditions, Swiss biotech AC ...

GSK goes down ph. 2 HPV injection over absence of best-in-class prospective

.GSK has actually junked a stage 2 individual papillomavirus (HPV) injection coming from its pipelin...

OS Therapies refiles $6M IPO to money HER2 medication, preclinical ADCs

.OS Therapies will specify on the NYSE American supply substitution today via a $6.4 thousand IPO th...

ALX's fizzling CD47 response price sends sell spiraling down

.ALX Oncology's period 2 stomach cancer cells feedback cost has actually weakened. After viewing its...

Ionis centers eye health condition coming from intendeds of Roche-partnered possibility after data let down

.Another of Ionis Pharmaceuticals' essential midphase readouts has fallen short of desires, urging t...

Biogen's chief executive officer mentioned no dangerous deals in 2023. He prepares to become bold

.While Biogen's pharma peers are looking for late-stage resources with little bit of risk, chief exe...

Instil refills pipe in $2B biobucks deal with ImmunOnco

.Instil Bio has actually been actually a biotech in search of a pipe after it junked its lead resour...

Biogen leaves Denali Alzheimer's collab

.Biogen has restored liberties to a very early Alzheimer's illness course to Denali Rehabs, leaving ...

Takeda water faucets brand new mind people oncology service-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings as...